November 19, 2026 · Journal of hepatology · DOI: 10.1016/j.jhep.2026.11.009

Checkpoint Inhibition during primary hepatitis E virus infection alters memory development of virus-specific T-cells in humans.

Listen to this summary

This study asks how PD-1 blockade during a primary hepatitis E virus (HEV) infection shapes the expansion and memory fate of de novo virus-specific CD8+ T-cells in humans. Comparing patients receiving immune checkpoint inhibitors with untreated patients, the authors found that treated patients' HEV-specific CD8+ T-cells showed enhanced expansion, cytotoxicity, and terminal differentiation, retaining a cytotoxic program and long-lived effector-like features rather than forming classical memory subsets. Although these cells persisted for over two years, their functional recall responses were diminished, suggesting PD-1 signaling during primary priming regulates antiviral CD8+ T-cell memory fate with implications for viral infection, vaccination, and immunotherapy.

Lara Kelsch, Jakob Arnold, Michelle Maas, Maria Borkmann, David Rafei, Giuseppe Rusignuolo, Sian Llewellyn-Lacey, David A Price, Bertram Bengsch, Maike Hofmann, Robert Thimme, Christoph Neumann-Haefelin, Sagar, Tobias Boettler

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play